Almirall
ALM
$9.34
+4.94%
Almonty Industries Inc. is a tungsten-focused mining company engaged in the mining, processing, and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Portugal, while developing the Sangdong Mine in South Korea — one of the world's largest undeveloped tungsten deposits — alongside early-stage projects in Spain and Montana. The company occupies a distinct strategic niche as one of the few non-Chinese tungsten producers at scale, positioning it as a critical-minerals supply-chain play rather than a diversified miner. The current investor narrative is dominated by the Sangdong development timeline and the broader Western push to secure critical mineral supply chains amid escalating export restrictions from China, with recent headlines emphasizing national-security-driven investment into North American and allied tungsten and antimony production. This geopolitical tailwind has driven a sharp re-rating of the stock over the past year, though the company remains pre-profitability at the consolidated level and highly sensitive to development execution and financing conditions.…
ALM
Almirall
$9.34
Investment Opinion: Should I buy ALM Today?
The synthesized recommendation is Hold with a speculative bias. The core thesis is that Almonty offers unique exposure to the Western critical minerals supply chain through its Sangdong tungsten project, but the current valuation of 77.3x PS and deeply negative free cash flow of -$79.9 million mean the stock is a high-risk execution bet rather than a fundamental value play. The analyst consensus of 'strong_buy' with a $24.36 average target (+105% upside) provides a bullish anchor, but the 151% spread between the low ($12.86) and high ($32.27) targets signals extreme uncertainty.
Supporting evidence for a constructive stance includes the Q1 2026 revenue surge to $25.4 million (up 191% sequentially), gross margin expansion to 51.2%, a forward PE of 10.0x based on estimated EPS of $2.415, and a strong liquidity position with $259.9 million cash and a 3.89 current ratio. The strategic tailwind from $12 billion in Western critical mineral initiatives and record Chinese export restrictions directly benefits Almonty as one of the few non-Chinese tungsten producers at scale. However, these positives are offset by the 77.3x PS ratio, -$79.9 million TTM FCF, -45.3% ROE, and 45% share dilution over the past year.
The biggest risks that could invalidate the thesis are Sangdong development delays, further equity dilution, and a sharp decline in tungsten prices. This Hold would upgrade to Buy if Sangdong demonstrates sustained production at scale and free cash flow turns positive, or if the PS ratio compresses below 20x on rising revenue. It would downgrade to Sell if Sangdong commissioning slips materially, if another large equity raise occurs, or if revenue growth decelerates below 20% sequentially. Relative to its own history, the PS ratio of 77.3x sits in the middle-to-upper portion of its 15x-364x range, while the PB of 7.03x is in the lower half of its 2.1x-82.3x band — suggesting the stock is not at historical extremes but remains expensive on a sales basis.
Sign up to view all
ALM 12-Month Price Forecast
Almonty presents a classic pre-production mining binary: the forward PE of 10.0x implies the stock is cheap if Sangdong delivers, but the 77.3x PS ratio and -$79.9 million TTM FCF mean it is expensive if execution slips. The Q1 2026 revenue jump to $25.4 million and 51.2% gross margin provide the first tangible evidence the ramp is progressing, and the strategic tailwind from $12 billion in Western critical mineral initiatives is real. However, the stock's 35.2% one-month decline and 48.2% six-month relative weakness versus the S&P 500 show the market is demanding proof, not promises. I would upgrade to bullish if Sangdong achieves commercial production and quarterly revenue exceeds $50 million, or downgrade to bearish if another equity raise occurs or free cash flow remains negative through 2027. At $11.87, the risk/reward is balanced but skewed toward speculation rather than investment.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Almirall's 12-month outlook, with a consensus price target around $23.98 and implied upside of +156.7% versus the current price.
Average Target
$23.98
0 analysts
Implied Upside
+156.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$13 - $33
Analyst target range
Coverage is robust for a company of this size, with 12 analysts contributing to a consensus recommendation of "strong_buy" (recommendation mean of 1.18 on a 1–5 scale where 1 is Strong Buy). The average target price of $24.36 implies roughly +105% upside from the current $11.87, a strikingly bullish consensus that stands in sharp contrast to the stock's recent -35.2% one-month decline. Consensus estimated EPS of $2.415 and estimated revenue of $1.276 billion for the forward period underscore that analysts are modeling a full-scale Sangdong production ramp, and the bullish tilt is corroborated by the institutional ratings history, which shows a steady stream of reiterated Buy/Outperform ratings from DA Davidson, Oppenheimer, and B. Riley through 2026 with no downgrades.
The target range is exceptionally wide, from a low of $12.86 (just +8% above the current price) to a high of $32.27 (+172%), a spread of roughly 151% of the current price that signals very high uncertainty about the Sangdong timeline and tungsten price assumptions. The high target likely assumes on-schedule Sangdong commissioning, favorable tungsten pricing amid Chinese export restrictions, and multiple expansion on accelerating earnings; the low target appears to price in development delays, continued cash burn, and dilution from further equity raises. The persistence of Buy ratings even as the stock has fallen more than 50% from its highs suggests analysts view the selloff as a valuation reset rather than a fundamental deterioration — but the wide dispersion and the stock's 1.398 beta mean investors should treat the consensus target as a high-conviction directional signal with substantial execution risk attached.
Drowning in data?
Find the real signal!
Bulls vs Bears: ALM Investment Factors
The bear case currently has stronger near-term evidence, with the stock down 35.2% over one month, 28.5% over three months, and trading at just 33.9% of its 52-week range amid deeply negative free cash flow of -$79.9 million and a PS ratio of 77.3x. However, the bull case rests on a powerful forward-looking catalyst: 12 analysts maintain a 'strong_buy' consensus with a $24.36 average target (+105% upside), and the forward PE of 10.0x implies a dramatic earnings inflection from the Sangdong ramp. The single most important tension is whether Sangdong commissioning stays on schedule and tungsten prices hold amid Chinese export restrictions — if it does, the forward PE makes the stock look cheap; if it slips, the 77.3x PS multiple offers no support. The Q1 2026 revenue jump to $25.4 million and 51.2% gross margin provide the first tangible evidence the ramp is progressing, but one quarter does not resolve the debate. Until Sangdong demonstrates sustained production at scale, the stock will remain a high-beta (1.398) binary bet on execution.
Bullish
- Analyst consensus strong buy with 105% upside: 12 analysts rate ALM a consensus 'strong_buy' (recommendation mean 1.18), with an average target price of $24.36 implying roughly +105% upside from the current $11.87. The target range of $12.86 to $32.27 remains entirely above the current price, and institutional ratings from DA Davidson, Oppenheimer, and B. Riley have been reiterated without downgrades through 2026.
- Forward PE of 10x implies massive earnings inflection: The forward PE of 10.0x, based on consensus estimated EPS of $2.415, sits in line with or below typical industrial materials sector norms (10x-15x). This suggests that if the Sangdong ramp materializes, the stock is not expensive despite the trailing PE of -15.5x and negative trailing EPS of -$0.064.
- Q1 2026 revenue surged 191% sequentially: Q1 2026 revenue of $25.4 million jumped from $8.7 million in both Q4 2025 and Q3 2025, a 191% sequential increase. Gross margin also expanded to 51.2% in Q1 2026 from 15.1% in Q4 2025 and 14.4% in Q3 2025, reflecting a mix shift toward higher-grade concentrate.
- Strategic non-Chinese tungsten supply chain play: Almonty is one of the few non-Chinese tungsten producers at scale, with the Sangdong Mine in South Korea described as one of the world's largest undeveloped tungsten deposits. Recent news highlights a $12 billion Western critical mineral initiative and record global export restrictions, directly benefiting Almonty's strategic positioning.
Bearish
- PS ratio of 77.3x is 2,500% above sector norms: The price-to-sales ratio of 77.3x dwarfs typical industrial materials sector PS ratios of 1x-3x, representing a premium of more than 2,500%. EV/Sales of 34.1x and PB of 7.03x further confirm the market is capitalizing future production, leaving little margin for execution error.
- Deeply negative free cash flow and cash burn: TTM free cash flow is -$79.9 million, with Q1 2026 FCF of -$12.1 million driven by $21.8 million in quarterly capital expenditure. ROE of -45.3% reflects ongoing value destruction on the equity base, and the company remains pre-profitability at the consolidated level.
- Severe recent price deterioration and relative weakness: The stock is down 35.2% over one month and 28.5% over three months, with 1-month relative strength versus the S&P 500 at -37.4% and 6-month relative strength at -48.2%. At $11.87, it sits at just 33.9% of its 52-week range (low $5.435, high $24.41), having surrendered more than half its peak value.
- Extreme earnings volatility and non-cash distortions: Q4 2025 posted a net loss of $102.3 million driven by a $91.2 million non-cash other expense, while Q3 2025 showed $33.2 million net income from a $36.5 million other-income gain. This lumpy, non-operating-driven earnings pattern makes reported profitability unreliable and highlights dependence on the Sangdong ramp.
ALM Technical Analysis
Almonty is in a volatile, range-bound consolidation phase following a powerful multi-year advance, with the stock up 51.6% over the trailing twelve months but down 33.6% over six months and 28.5% over three months. At a current price of $11.87, the stock sits at just 33.9% of its 52-week range (low of $5.435, high of $24.41), meaning it has surrendered more than half of its peak value despite the positive one-year return. This positioning suggests the stock is in a corrective phase within a longer-term uptrend — neither a clean momentum breakout nor a deep-value falling knife, but a high-beta name digesting an extended prior move.
Short-term momentum is decisively negative and diverging sharply from the longer-term trend: the 1-month change of -35.2% and 3-month change of -28.5% contrast starkly with the +51.6% 1-year gain, signaling a trend reversal or at minimum a severe mean-reversion event. Relative strength versus the S&P 500 confirms the deterioration, with 1-month relative strength of -37.4% and 6-month relative strength of -48.2%, even as the 1-year relative strength remains positive at +35.6%. The recent bounce from $11.57 to $11.87 (+2.6% on the day) is a marginal stabilization signal, but with volume of 6.24 million shares and a short ratio of 2.99 days, there is no evidence yet of a durable momentum inflection.
Key technical levels are well-defined: support rests at the 52-week low of $5.435, roughly 54% below the current price, while resistance sits at the 52-week high of $24.41, about 106% above. A breakdown below the recent $10.95–$11.57 congestion zone would open the door to a retest of the lows, whereas reclaiming the $15–$16 area would be the first meaningful sign of trend repair. With a beta of 1.398, the stock is roughly 40% more volatile than the broader market, and a maximum drawdown of -53.25% underscores the position-sizing and risk-management demands of this name.
Beta
1.40
1.40x market volatility
Max Drawdown
-62.3%
Largest decline past year
52-Week Range
$5-$24
Price range past year
Annual Return
+11.5%
Cumulative gain past year
| Period | ALM Return | S&P 500 |
|---|---|---|
| 1m | -36.3% | -0.1% |
| 3m | -34.1% | +4.7% |
| 6m | -57.4% | +8.3% |
| 1y | +11.5% | +15.2% |
| ytd | +6.1% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ALM Fundamental Analysis
Revenue trajectory is highly uneven and development-stage in character: the most recent quarter (Q1 2026) posted revenue of $25.4 million, a dramatic jump from $8.7 million in Q4 2025 and $8.7 million in Q3 2025, though the prior quarters reflect the pre-ramp Panasqueira base. The Q4 2025 quarter was exceptionally weak at $8.7 million with a net loss of $102.3 million, driven largely by a $91.2 million non-cash other expense item, while Q3 2025 showed $8.7 million in revenue and $33.2 million in net income from a $36.5 million other-income gain. The multi-quarter pattern is one of small, lumpy operating revenue punctuated by large non-operating items, implying that the investment case rests on the Sangdong ramp rather than the current revenue base.
Profitability remains fragile at the operating level despite a headline gross margin of 51.2% in Q1 2026 (gross profit of $13.0 million on $25.4 million revenue), which is well above the 10.5% gross margin shown in the summary valuation data and reflects the mix shift toward higher-grade concentrate. However, Q1 2026 still produced a net loss of $5.3 million (net margin of -20.7%) and negative EBITDA of $1.77 million, with operating income of just $2.2 million offset by $4.76 million in other expenses and a $2.75 million tax charge. The trailing net margin of -4.98% and operating margin of -86.6% in the summary data highlight that profitability is not yet sustainable, and the Q4 2025 net loss of $102.3 million on an -11.7x net income ratio illustrates how volatile reported earnings can be for this name.
Balance sheet and cash flow metrics present a mixed picture: the current ratio of 3.89 and cash position of $259.9 million at Q1 2026 provide substantial near-term liquidity, and debt-to-equity of 0.453 is moderate. However, free cash flow remains deeply negative — TTM FCF of -$79.9 million and Q1 2026 FCF of -$12.1 million — driven by $21.8 million in quarterly capital expenditure, and ROE of -45.3% reflects ongoing value destruction on the equity base. The company has relied heavily on equity issuance to fund development, raising $193.1 million in Q4 2025 and $123.3 million in Q3 2025, which explains the cash build but also the dilution risk that overhangs the equity story.
Quarterly Revenue
$25400000.0B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
51.2%
Latest Quarter
Free Cash Flow
$-79883000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ALM Overvalued?
Because Almonty reported negative trailing net income (EPS of -$0.064), the trailing PE of -15.5x is not meaningful, and the negative EBITDA of -$1.77 million in Q1 2026 makes EV/EBITDA of -85.6x equally unusable; the appropriate primary metric is therefore the price-to-sales ratio, which stands at an extraordinarily elevated 77.3x. The forward PE of 10.0x, based on consensus estimated EPS of $2.415, implies the market expects a dramatic earnings inflection — a gap between trailing and forward earnings power that is among the widest in the basic materials sector and signals that the entire valuation rests on successful Sangdong ramp-up.
Against typical industrial materials sector averages (where PS ratios generally range from 1x to 3x and forward PEs cluster in the 10x–15x range), Almonty's 77.3x PS represents a premium of more than 2,500% to sector norms, while its 10.0x forward PE is roughly in line with or slightly below the sector. This bifurcation is the crux of the valuation debate: the PS multiple prices in a future revenue base many times larger than the current $25.4 million quarterly run-rate, while the forward PE suggests that if that revenue materializes with reasonable margins, the stock is not expensive. The PB ratio of 7.03x and EV/Sales of 34.1x further confirm that the market is capitalizing future production, not current financials.
Historically, Almonty's PS ratio has ranged from roughly 15x (Q2 2024) to 364x (Q4 2025), with the current 77.3x sitting in the middle-to-upper portion of that band but far below the Q4 2025 peak. The PB ratio of 7.03x compares to a historical range of roughly 2.1x (Q1 2024) to 82.3x (Q2 2025), placing the current reading in the lower half of its own recent band — a function of the large equity raises that boosted book value. The takeaway is that valuation is not at historical extremes on a book basis, but the PS multiple remains in rarefied territory that leaves little margin for execution error.
PE
-15.5x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-85.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are substantial for a pre-profitability miner. TTM free cash flow of -$79.9 million and Q1 2026 FCF of -$12.1 million reflect heavy capital expenditure of $21.8 million per quarter, while ROE of -45.3% signals ongoing value destruction. The company has relied on equity issuance to fund development, raising $193.1 million in Q4 2025 and $123.3 million in Q3 2025, which grew shares outstanding from 192.1 million in Q2 2025 to 278.4 million in Q1 2026 — a 45% dilution. Although the current ratio of 3.89 and $259.9 million cash position provide near-term liquidity, continued cash burn could necessitate further raises, pressuring the share price. Revenue concentration is acute: the entire investment case rests on the Sangdong ramp, as current operations at Panasqueira generated only $25.4 million in Q1 2026 revenue against a $2.5 billion market cap.
Market and competitive risks are elevated given the stock's extreme valuation and volatility. The PS ratio of 77.3x is more than 2,500% above typical industrial materials sector norms of 1x-3x, leaving no margin for execution error; any delay in Sangdong commissioning could trigger severe multiple compression. Beta of 1.398 means the stock is roughly 40% more volatile than the broader market, and maximum drawdown of -53.25% illustrates the downside potential. Recent news of a $12 billion Western critical mineral initiative and record export restrictions provides a tailwind, but also invites competitive responses from other non-Chinese producers and potential policy shifts. The stock's 1-month relative strength of -37.4% versus the S&P 500 highlights how quickly sentiment can reverse in this name.
The worst-case scenario involves Sangdong development delays, cost overruns, or a sharp decline in tungsten prices, compounded by further equity dilution. In this scenario, the stock could retest its 52-week low of $5.435, representing a decline of approximately 54% from the current $11.87. The analyst low target of $12.86 offers little downside protection, and the historical maximum drawdown of -53.25% confirms such a move is plausible. An investor could lose 50% or more from current levels if the bear case materializes, making position sizing critical.
FAQ
The most severe risk is execution risk on the Sangdong Mine, as the entire investment case rests on a project that is not yet in commercial production. Financial risk is high: TTM free cash flow of -$79.9 million, ROE of -45.3%, and a 45% increase in shares outstanding over the past year from equity raises create dilution and funding concerns. Valuation risk is extreme, with a 77.3x PS ratio leaving no margin for error — any delay could trigger a sharp multiple compression. Market risk is amplified by beta of 1.398 and a maximum drawdown of -53.25%, meaning the stock could lose half its value in a adverse scenario, with the 52-week low of $5.435 representing 54% downside from current levels.
The 12-month forecast is highly uncertain, with three scenarios: a bull case (30% probability) targeting $24.36-$32.27 if Sangdong ramps on schedule and tungsten prices stay elevated; a base case (50% probability) targeting $12.86-$24.36 with gradual progress and minor delays; and a bear case (20% probability) targeting $5.435-$12.86 if development slips or another equity raise occurs. The base case is most likely, assuming Sangdong reaches commercial production within 12 months but below full capacity, with quarterly revenue growing to $40-60 million. The key assumption is that the $259.9 million cash position is sufficient to fund development without further dilution.
ALM is overvalued on trailing metrics but potentially undervalued on forward estimates, creating a binary valuation debate. The PS ratio of 77.3x is more than 2,500% above typical industrial materials sector norms of 1x-3x, and EV/Sales of 34.1x confirms the market is capitalizing future production. However, the forward PE of 10.0x based on estimated EPS of $2.415 is in line with or below sector averages, implying that if Sangdong delivers, the stock is reasonably priced. The market is clearly pricing in a successful ramp — the question is whether execution risk justifies the 77.3x sales multiple.
ALM is a high-risk, high-reward speculative buy for investors who believe in the Sangdong tungsten ramp and the Western critical minerals thesis. The analyst consensus is 'strong_buy' with a $24.36 average target, implying +105% upside from $11.87, and the forward PE of 10.0x suggests the stock is cheap if estimates of $2.415 EPS materialize. However, the stock is down 35.2% over one month, has TTM free cash flow of -$79.9 million, and trades at 77.3x sales, meaning the downside risk is equally significant. It is a good buy only for those with a long time horizon, high volatility tolerance (beta 1.398), and position sizes that can withstand a 50% drawdown.
ALM is suitable only for long-term investors with a minimum holding period of 3-5 years, as the Sangdong Mine development and ramp-up will take years to fully materialize. The stock's beta of 1.398, maximum drawdown of -53.25%, and 35.2% one-month decline make it unsuitable for short-term trading unless one is a momentum trader with strict risk controls. No dividend is paid, so returns depend entirely on capital appreciation from successful project execution. Earnings visibility is low given the lumpy, non-operating-driven quarterly results, meaning investors should expect volatility and focus on production milestones rather than quarterly EPS.